ClinicalTrials.gg
Drug

Mivavotinib clinical trials

Also written TAK-659.

Includes 10 studies of TAK-659.

studies test it
13
open now
0
in phase 3
0
first study started
2013

How each study uses mivavotinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Spleen Tyrosine Kinase Inhibitor TAK659
2
syk Inhibitor TAK-659
2
syk Inhibitor TAK659
2
syk-Inhibitor TAK-659
2
syk-Inhibitor TAK659
2

Development codes

TAK-659
2
CB-659
1

Studies by the year they started

13 studies that test it; most in 2019 (4)

Studies that test mivavotinib, by start year
YearStudies
20131
20151
20161
20172
20183
20194
20221

By phase

A phase 1/2 study counts in both.

Phase 1
11
Phase 2
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 3

Calithera Biosciences, Inc (10) · Northwestern University (1) · M.D. Anderson Cancer Center (1) · H Scott Boswell (1)

Often tested with

Tested in the same studies.

Bempegaldesleukin (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses mivavotinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Given beside what is tested · 2 — mivavotinib is usual care or a partner of the new treatment

Codes

What other systems call mivavotinib · ClinicalTrials.gg INT015704

  • UNII (FDA) 8QR88H79VXMIVAVOTINIBConfirmed FDA, Wikidata
  • Wikidata Q105337798mivavotinibConfirmed FDA, Wikidata
  • NCI Thesaurus C113162MivavotinibOne source FDA
  • DrugBank DB16849One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.